Manufacturing Fees. The initial Manufacturing Fees to be paid by COMPANY to DPT are listed in Schedule A. The parties hereto agree that the Manufacturing Fees set out in Schedule A shall be re negotiated, in good faith, at the beginning of each calendar year. If the parties are unable to agree on a re-negotiated price at least thirty (30) days prior to the start of a new twelve (12) month period, then this Agreement, effective the first day of January of the new twelve (12) month period, shall continue in force with prices being adjusted to reflect the change in the most recently published monthly “Producer Price Index for Pharmaceutical Preparation Manufacturing”, issued by the Bureau of Labor Statistics, US Department of Labor (“PPI”), or comparable successor index, in July of the preceding year as compared to the same month of the year prior thereto until such time as to when price negotiation can be completed. In addition, Manufacturing Fees are based on annual volumes for Products. DPT reserves the right to re-evaluate Manufacturing Fees at the beginning of the second calendar year (and each calendar year thereafter) in the event that actual volumes differ from those volumes listed in Schedule A. by more than ten percent (10%). Prices for new Products or new Product sizes, new batch sizes or product configuration changes not initially included in Schedule A, shall be negotiated and DPT and COMPANY shall arrive at a mutual agreement with respect to prices at the time said new Products or new Product sizes are added to Schedule A. If a negotiated price cannot be agreed upon, final pricing for any of the above will be settled in accordance with paragraph 12.6 (b) below.
Manufacturing Fees. The Manufacturing Fee shall be USD $0.12 / tablet (packaged in bottles of 30 or 100 count) and USD $1.85 per bottle for the sample pack of 7 counts. This price is based on the maximum cost of API at $700/kg and subject to review from time to time if the cost of API changes in accordance with Section 5.2.
Manufacturing Fees. 5.1 Manufacturing Fees and Payment. The initial fees to be paid by Company to Alpex for the Finished Product are listed in Appendix C (as may be adjusted in accordance with Section 5.2, the “Manufacturing Fees”). Payment for all deliveries of Finished Product to Company will be made in U.S. dollars. Alpex will render an invoice for each shipment of the Finished Product upon delivery. Company will pay amounts properly due under the relevant invoice within forty-five (45) days from the date it receives the invoice.
Manufacturing Fees. 7.1 In consideration for the services provided to Xxxxxx under this Agreement, Xxxxxx shall pay to Oravax the following Manufacturing Fees:
Manufacturing Fees. The initial Manufacturing Fees to be paid by COMPANY to DPT are listed in Schedule A. The parties hereto agree that the Manufacturing Fees set out in Schedule A shall be ***. In addition, *** are based on ***. *** in the event that ***. If the parties are *** in the most recently published monthly ***. Prices for new Products or new Product sizes, not initially included in Schedule A, shall be negotiated and DPT and COMPANY shall arrive at a mutual agreement with respect to prices at the time said new Products or new Product sizes are added to Schedule A. If a negotiated price cannot be agreed upon, final pricing for any of the above will be settled in accordance with paragraph 13.6(b) below.
Manufacturing Fees. The initial Manufacturing Fees to be paid by COMPANY to DPT are set forth in Schedule C. DPT reserves the right to raise the Manufacturing Fees if change(s) to Applicable Law, including, but not limited to GMP or changes made under Article 6, increase the cost of manufacturing of the Product or of any other activities contemplated under this Agreement. In addition, the Parties hereto agree that increases to the Manufacturing Fees set forth in Schedule C shall be negotiated, in good faith, at the beginning of each calendar year. If the Parties are unable to agree on a re-negotiated price at [***]. [***]. In addition, Manufacturing Fees are based on annual volumes for Product. [***]. Prices for new Product or new Product sizes, new batch sizes or Product configuration changes not initially included in Schedule C, shall be negotiated and DPT and COMPANY shall arrive at a mutual agreement with respect to prices at the time said new Product or new Product sizes are added to Schedule B. Costs associated with establishing, testing or manufacturing components or new materials such as reference standards, reagents, art charges, die costs, molding or tooling costs, plate costs, and packing equipment change parts will be invoiced to COMPANY at DPT’s cost on a net thirty (30) basis and COMPANY agrees to reimburse DPT for any such authorized expenditures made on COMPANY’s behalf.
Manufacturing Fees. 4.1 As compensation to Fermic for manufacturing, storing, and labor involved in packaging and handling the AstaXin(R), and for all of its other services under this Agreement, Igene shall pay Fermic a rental fee of $USD[ * ] per cubic meter of fermentation capacity per month, as may be reduced in accordance with Section 4.8 below.
Manufacturing Fees. The initial Manufacturing Fees to be paid by AUXILIUM to DPT are listed in Schedule A. The parties hereto agree that the Manufacturing Fees set out in Schedule A shall be re-negotiated, in good faith, at [**]. If the parties are unable to agree on a re-negotiated price at least [**] prior to the start of a [**] period, then this Agreement, effective the [**] of the [**], shall continue in force with prices being adjusted to reflect the change in the monthly PPI, or comparable successor index, in [**] of the preceding [**] compared to the same [**] prior thereto, until such time as to when price negotiation can be completed. Prices for new Product sizes, new batch sizes or Product configuration changes not initially included in Schedule A, shall be negotiated and DPT and AUXILIUM shall arrive at a mutual agreement with respect to prices at the time said new Product sizes are added to Schedule A. If a negotiated price cannot be agreed upon, final pricing for any of the above will be settled in accordance with paragraph 12.6 below.
Manufacturing Fees. During the term of this Agreement, Buyer ------------------ will pay Seller (a) a fee (the "Leased Salaried Employee Fee") for the use by Seller of the Leased Salaried Employees which shall accrue on a daily basis and shall equal the costs attributable to the Leased Salaried Employees used by Seller to manufacture Products during each week of the term of this Agreement based upon the daily rate of each Leased Salaried Employee set forth opposite such Leased Salaried Employee's name on column D of Part II of Exhibit C hereto, (b) a fee (the "Leased Hourly Employee Fee" and, collectively with the Leased Salaried Employee Fee, the "Leased Employee Fee") for the use by Seller of the Leased Hourly Employees which shall accrue on an hourly basis and shall equal the product of (i) the costs attributable to the Leased Hourly Employees used to manufacture Products during each week of the term of this Agreement based upon the hourly rate of each Leased Hourly Employee set forth opposite such Leased Hourly Employee's name on column D of Part I of Exhibit C hereto, multiplied by (ii) the number of hours worked by such Leased Hourly Employees during each such week, and (c) a fee (the "Leased Space Fee") for the use by Seller of the Leased Space which shall accrue on a monthly basis and shall be calculated in accordance with the schedule attached hereto as Exhibit B. Payment by Buyer to Seller of the Leased Employee Fee and the Leased Space Fee in accordance with the terms of this Agreement shall constitute payment in full for any Products manufactured by Seller during the term of this Agreement. Buyer shall also pay the fees set forth on Exhibit D for miscellaneous administrative and accounting services. Buyer and Seller acknowledge that the number of Leased Employees will decrease over the term of this Agreement substantially as set forth on Exhibit A attached hereto.
Manufacturing Fees. The Manufacturing Fees for the Finished Product shall be based upon the quantities of the Finished Product purchased by Dance during the then-current calendar year, as follows below. Once the annual order quantity for the next tier is reached, all future pricing will convert to the pricing for the new tier (unless order quantity subsequently declines). For example, if Dance place an order for 1 million bottles to be delivered in March 2019 and 2.5 million bottles to be delivered in September 2019, then Dance will pay [*] Euros per bottle for each of the 3.5 million bottles purchased in 2019, and Dance first order in 2020 will also be at the same price ([*] Euros) because we are assuming sales growth year-to-year. However, in the unlikely case there is a decline in sales such that Dance purchases less than 3 million bottles by the end of a future year, then Dance will need to pay an additional [*]Euros for any bottles purchased that year, for a total of [*] Euros per bottle. In addition to the cost below a cost of [*] Euro per pack order will be invoiced. Aggregate Quantity Ordered During Then-Current Calendar Year Price per bottle Finished Drug Product* (Euro) less than [*] bottles of Finished Drug Product [*] equal to or more than [*] bottles, but less than [*] bottles [*] equal to or more than [*] bottles [*] * The Price does not include any cost for API or Primary Packaging material. Dance will purchase the API and Primary Packaging material directly from third party manufactures under separate supply agreements and have these supplies delivered to Rechon. Rechon will include a service fee for receiving and storing these materials for Dance at Rechon’s facility, of [*] of all Primary Packaging orders and [*] of insulin orders. The service fee will be applicable for all API or Primary Packaging material delivered to Rechon after July 2014. Future price adjustments will be considered on an annual basis to account for improvements in production efficiency at higher volumes, as well as changes in the price of materials or production costs for Finished Products due to inflation, raw material shortages, quality issues, market conditions or other factors, which the Parties may deem appropriate. Any increase in the price contemplated under this Appendix B shall not exceed any increases in the cost to Rechon of all raw materials, regulatory compliance costs directly associated with production of Finished Product and all directly allocated labor and is not to exc...
